Oxaliplatin‐induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70396 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Georg W Wurschi und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy and Radiation Oncology, Jena University Hospital, Jena, Germany. Hauptthemen laut MEDLINE: Oxaliplatin, Rectal Neoplasms, Neoadjuvant Therapy, Quality of Life. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oxaliplatin‐based regimens are increasingly used in total neoadjuvant therapy (TNT) for locally advanced rectal cancer, frequently causing dose‐limiting chemotherapy‐induced peripheral neuropathy (CIPN), whose extent and impact on health‐related quality of life (HrQoL) remain insufficiently characterized. The optimal duration and intensity of chemotherapy within TNT for tumor response and toxicity remain unclear. This retrospective multicenter study (DRKS00033000) assessed the dose–response relationship of CIPN with cumulative oxaliplatin dose (cOXAd) and its impact on HrQoL. A total of 227 patients (164 men) with a median age of 63 (Q1–Q3: 54–68) years, who underwent oxaliplatin‐based TNT between 2015 and 2024, were analyzed. HrQoL was assessed cross‐sectionally during follow‐up using the EORTC QLQ‐C30 and QLQ‐CIPN20 questionnaires. Multivariable logistic regression was applied to evaluate the relationship between cOXAd and CIPN grade ≥2, and known‐group comparisons examined differences in HrQoL scores. At follow‐up, 61 patients (26.9%) experienced CIPN grade ≥2 after a median cOXAd of 758.8 mg/m 2 . Higher cOXAd was associated with an increased likelihood of CIPN grade ≥2 (adjusted OR 1.004, 95% CI: 1.002–1.007), corresponding to a 7.8% higher probability per additional FOLFOX cycle (+85 mg/m 2 cOXAd). Patients with CIPN grade ≥2 reported lower mean QLQ‐C30 Global Health Scores and Summary Scores (−13.0 and −12.4 points; Cohen's d = −0.59 and −0.68) and higher QLQ‐CIPN20 Summary Scores (+23.9 points; Cohen's d = 1.65) compared to those without CIPN. These findings indicate that CIPN is a common dose‐dependent toxicity of oxaliplatin‐based TNT, associated with considerably reduced HrQoL and markedly increased neuropathy‐related symptom burden at follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiotherapy and Radiation Oncology, Jena University Hospital, Jena, Germany.
- Comprehensive Cancer Center Central Germany (CCCG), Partner Site Jena, Jena, Germany.
- Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Leipzig, Germany.
- Comprehensive Cancer Center Central Germany (CCCG), Partner Site Leipzig, Leipzig, Germany.
- Department of Radiotherapy and Radiation Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
- Department of Radiotherapy, Hannover Medical School, Hannover, Germany.
ORCID-Profile: Georg W Wurschi, Felix Ehret, Alexander Fabian
Zitieren
APA
Wurschi, G. W., Hinz, A., Schneider, M., Becker, J. N., Frerker, B., Vorbach, S. M., Ehret, F., Diefenhardt, M., Schunn, F., von Gruben, M. E., Büttner, M., Hoffmann, E., Rühle, A., Beier, J., Ferdinandus, S., Trommer, M., Sahin, E. C., Hlouschek, J., Aninditha, K., …, & Pietschmann, K. (2026). Oxaliplatin‐induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life. International Journal of Cancer. https://doi.org/10.1002/ijc.70396
Vancouver
Wurschi GW, Hinz A, Schneider M, Becker JN, Frerker B, Vorbach SM, et al. Oxaliplatin‐induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life. International Journal of Cancer. 2026. doi:10.1002/ijc.70396
BibTeX
@article{Wurschi2026,
author = {Wurschi, Georg W and Hinz, Andreas and Schneider, Melanie and Becker, Jan-Niklas and Frerker, Bernd and Vorbach, Samuel M and Ehret, Felix and Diefenhardt, Markus and Schunn, Fabian and von Gruben, Maria-Elena and Büttner, Marcel and Hoffmann, Elgin and Rühle, Alexander and Beier, Josephine and Ferdinandus, Simone and Trommer, Maike and Sahin, Ezgi Ceren and Hlouschek, Julian and Aninditha, Kynann and von Ohlen, Daphne Schepers and Kaufmann, Justus and Depardon, Alina and Ha, Hai Minh and Kessler, Christopher and Cieslak, Adrianna and Trommer, Simon and Fabian, Alexander and Rißner, Florian and Römer, Maximilian and Pietschmann, Klaus},
title = {Oxaliplatin‐induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70396}
}
EUVIMED